secwatch / observer

8-K filed February 29, 2024, 6:59 PM ET ticker CC CIK 0001627223

leadership confidence high sentiment negative materiality 0.90

Chemours places CEO, CFO, and CAO on leave; appoints interim leaders

Chemours Co

CEO Mark Newman, CFO Jonathan Lock, and CAO Camela Wisel placed on administrative leave pending Audit Committee review.
Denise Dignam, President of Titanium Technologies, appointed Interim CEO effective Feb 28, 2024.
Matthew Abbott, SVP & Chief Enterprise Transformation Officer, appointed Interim CFO.
Administrative leave relates to ongoing Audit Committee review of preliminary 2023 financial estimates.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Camela Wisel

Vice President, Controller and Principal Accounting Officer

CC · Chemours Co

Effective: 2024-02-28
Filed: February 29, 2024, 6:59 PM ET

the Board placed President and Chief Executive Officer Mark Newman, Senior Vice President and Chief Financial Officer Jonathan Lock and Vice President, Controller and Principal Accounting Officer Camela Wisel on administrative leave

Departed

Jonathan Lock

Senior Vice President and Chief Financial Officer

CC · Chemours Co

Effective: 2024-02-28
Successor: Matthew Abbott
Filed: February 29, 2024, 6:59 PM ET

the Board placed President and Chief Executive Officer Mark Newman, Senior Vice President and Chief Financial Officer Jonathan Lock and Vice President, Controller and Principal Accounting Officer Camela Wisel on administrative leave

Departed

Mark Newman

President and Chief Executive Officer

CC · Chemours Co

Effective: 2024-02-28
Successor: Denise Dignam
Filed: February 29, 2024, 6:59 PM ET

the Board placed President and Chief Executive Officer Mark Newman, Senior Vice President and Chief Financial Officer Jonathan Lock and Vice President, Controller and Principal Accounting Officer Camela Wisel on administrative leave

Appointed (interim)

Matthew Abbott

Interim Chief Financial Officer

CC · Chemours Co

Effective: 2024-02-28
Filed: February 29, 2024, 6:59 PM ET

Matthew Abbott as the Interim Chief Financial Officer

Appointed (interim)

Denise Dignam

Interim Chief Executive Officer

CC · Chemours Co

Effective: 2024-02-28
Filed: February 29, 2024, 6:59 PM ET

appointed Denise Dignam as the Interim Chief Executive Officer

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Camela Wisel departed as Vice President, Controller and Principal Accounting Officer at Chemours Co.

Action: placed on administrative leave
Role: Vice President, Controller and Principal Accounting Officer

Exact text from the filing

the Board placed President and Chief Executive Officer Mark Newman, Senior Vice President and Chief Financial Officer Jonathan Lock and Vice President, Controller and Principal Accounting Officer Camela Wisel on administrative leave

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jonathan Lock departed as Senior Vice President and Chief Financial Officer at Chemours Co.

Action: placed on administrative leave
Role: Senior Vice President and Chief Financial Officer

Exact text from the filing

the Board placed President and Chief Executive Officer Mark Newman, Senior Vice President and Chief Financial Officer Jonathan Lock and Vice President, Controller and Principal Accounting Officer Camela Wisel on administrative leave

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Newman departed as President and Chief Executive Officer at Chemours Co.

Action: placed on administrative leave
Role: President and Chief Executive Officer

Exact text from the filing

the Board placed President and Chief Executive Officer Mark Newman, Senior Vice President and Chief Financial Officer Jonathan Lock and Vice President, Controller and Principal Accounting Officer Camela Wisel on administrative leave

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Matthew Abbott was appointed as Interim Chief Financial Officer at Chemours Co.

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

Matthew Abbott as the Interim Chief Financial Officer

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Denise Dignam was appointed as Interim Chief Executive Officer at Chemours Co.

Action: appointed
Role: Interim Chief Executive Officer

Exact text from the filing

appointed Denise Dignam as the Interim Chief Executive Officer

View on SEC.gov

Chemours Co filing history →

Source: SEC EDGAR

accession 0001193125-24-051931

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.